CMRX
Chimerix Inc
NASDAQ: CMRX · HEALTHCARE · BIOTECHNOLOGY
$8.54
+0.00% today
Updated 2026-04-29
Market cap
$801.08M
P/E ratio
—
P/S ratio
3,778.70x
EPS (TTM)
$-0.99
Dividend yield
—
52W range
$0 – $0
Volume
1.4M
Chimerix Inc (CMRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.72M | $12.10M | $33.72M | $4.37M | $4.04M | $10.76M | $5.70M | $4.49M | $7.22M | $12.52M | $5.37M | $1.98M | $33.82M | $324000.00 | $212000.00 |
| Revenue growth (YoY) | — | +605.6% | +178.7% | -87.0% | -7.6% | +166.4% | -47.0% | -21.2% | +60.6% | +73.5% | -57.1% | -63.2% | +1609.1% | -99.0% | -34.6% |
| Cost of revenue | — | $36.14M | $30.11M | $24.66M | $45.38M | $97.72M | $58.65M | $49.45M | $55.24M | $38.49M | $36.23M | $468000.00 | $447000.00 | $1000.00 | $0.00 |
| Gross profit | $1.72M | $12.10M | $3.61M | $-20.29M | $-41.34M | $10.76M | $5.70M | $-44.95M | $-48.02M | $-25.97M | $5.37M | $1.51M | $33.38M | $324000.00 | $212000.00 |
| Gross margin | 100.0% | 100.0% | 10.7% | -464.3% | -1023.2% | 100.0% | 100.0% | -1000.3% | -665.5% | -207.5% | 100.0% | 76.4% | 98.7% | 100.0% | 100.0% |
| R&D | $19.41M | $30.11M | $27.82M | $24.66M | $45.38M | $97.19M | $58.65M | $49.45M | $55.24M | $42.29M | $36.23M | $73.82M | $71.63M | $68.79M | $74.57M |
| SG&A | $7.61M | $6.99M | $8.68M | $8.33M | $17.53M | $31.82M | $25.01M | $27.15M | $23.58M | $21.17M | $13.66M | $18.67M | $22.13M | $24.60M | $22.20M |
| Operating income | $-25.30M | $-24.99M | $-2.78M | $-28.62M | $-58.87M | $-118.25M | $-77.95M | $-72.10M | $-71.61M | $13.54M | $-44.52M | $-173.40M | $-60.39M | $-93.06M | $-96.57M |
| Operating margin | -1475.5% | -206.5% | -8.3% | -654.9% | -1457.1% | -1098.8% | -1367.1% | -1604.4% | -992.3% | 108.2% | -828.7% | -8762.0% | -178.5% | -28723.8% | -45550.5% |
| EBITDA | $-25.09M | $-24.72M | $-2.50M | $-28.36M | $-58.58M | $-117.59M | $-76.89M | $-71.01M | $-70.75M | $-44.67M | $-44.11M | $-90.34M | $-60.39M | $-92.97M | $-96.47M |
| EBITDA margin | -1463.0% | -204.3% | -7.4% | -649.0% | -1450.1% | -1092.7% | -1348.5% | -1580.1% | -980.4% | -356.8% | -821.2% | -4565.1% | -178.5% | -28695.7% | -45506.1% |
| EBIT | $-25.30M | $-24.99M | $-2.78M | $-28.62M | $-58.87M | $-118.25M | $-77.95M | $-72.10M | $-71.61M | $-45.16M | $-44.52M | $-90.81M | $-60.49M | $-93.06M | $-96.57M |
| Interest expense | $154000.00 | $212000.00 | $0.00 | $1.23M | $1.23M | $879000.00 | $1.56M | $1.16M | $2.48M | $0.00 | $994000.00 | $165.61M | $2.92M | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-25.46M | $-25.59M | $-4.41M | $-36.45M | $-59.31M | $-117.37M | $-76.39M | $-70.98M | $-69.47M | $-173.65M | $-42.13M | $-255.79M | $172.17M | $-82.09M | $-88.39M |
| Net income growth (YoY) | — | -0.5% | +82.8% | -727.2% | -62.7% | -97.9% | +34.9% | +7.1% | +2.1% | -149.9% | +75.7% | -507.2% | +167.3% | -147.7% | -7.7% |
| Profit margin | -1484.4% | -211.5% | -13.1% | -834.0% | -1468.1% | -1090.6% | -1339.7% | -1579.5% | -962.8% | -1387.1% | -784.2% | -12925.5% | 509.0% | -25338.0% | -41692.0% |